You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 6, June 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Thyroid dysfunction in Down syndrome

S. M. Pueschel and J. C. Pezzullo

We investigated the thyroid function of 151 patients with Down syndrome. Compared with a control group of 89 siblings nearest in age to their brother or sister with Down syndrome, the mean thyroid-stimulating hormone (TSH) value was significantly higher in patients with Down syndrome than in subjects without Down syndrome. However, the mean thyroxine (T4) levels in both groups were nearly the same. In the Down syndrome group there was a trend for TSH values to increase and for T4 values to decrease with advancing age. Of the 151 patients with Down syndrome, ten had both significantly elevated TSH levels (greater than or equal to 9.5 microU/mL) and significantly decreased T4 levels (less than or equal to 5.5 micrograms/dL), 21 had only abnormally high TSH values, seven had only markedly increased T4 levels (greater than or equal to 12.0 micrograms/dL), and three had only significantly decreased T4 levels. The intellectual function of patients with both abnormal TSH and T4 levels was significantly lower (mean IQ, 41.7) than that of Down syndrome patients with only increased TSH values (mean IQ, 53.8) and that of Down syndrome patients with normal thyroid function (mean IQ, 55.3). This study provides further evidence that there is an increased prevalence of thyroid dysfunction in patients with Down syndrome.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increase in Incidence of Medically Treated Thyroid Disease in Children With Down Syndrome After Rerelease of American Academy of Pediatrics Health Supervision Guidelines
Carroll et al.
Pediatrics 2008;122:e493-e498.
ABSTRACT | FULL TEXT  

The Effect of Thyroxine Treatment Started in the Neonatal Period on Development and Growth of Two-Year-Old Down Syndrome Children: A Randomized Clinical Trial
van Trotsenburg et al.
J. Clin. Endocrinol. Metab. 2005;90:3304-3311.
ABSTRACT | FULL TEXT  

Longitudinal study of thyroid function in Down's syndrome in the first two decades
Gibson et al.
Arch. Dis. Child. 2005;90:574-578.
ABSTRACT | FULL TEXT  

A search for the evidence supporting community paediatric practice
Rudolf et al.
Arch. Dis. Child. 1999;80:257-261.
ABSTRACT | FULL TEXT  

Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity
Karlsson et al.
Arch. Dis. Child. 1998;79:242-245.
ABSTRACT | FULL TEXT  

Dietary Practices, Physical Activity, and Body-Mass Index in a Selected Population of Down Syndrome Children and Their Siblings
Sharav and Bowman
CLIN PEDIATR 1992;31:341-344.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.